Clinical Trial Update: Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD) [NA]

View source ↗

Summary

This document reports an update on a clinical trial investigating how genetic polymorphisms influence ranibizumab treatment in wet age-related macular degenerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Age-Related Macular Degeneration | NA | Status: UNKNOWN